Male breast cancer (MBC) is a rare disease. It accounts for a less than 1% of total malignant diseases and for a less than 1% of all breast cancer cases [1]. Besides the fact that it is much less frequent than a female breast cancer (FBC), MBC is a disease that deserves a full attention of the whole society. Although global incidence of MBC of around 8000 cases [2] is still relatively low, the rise in the incidence from 0.86 to 1.08 per 100000 in twenty five year period (from 1973 to 1998) [3] and the increment in the lifetime risk of getting MBC to 1 in 1000 [4] in the United States of America, should raise the awareness of MBC among all health care professionals.
